Hostname: page-component-76d6cb85b7-6jg5l Total loading time: 0 Render date: 2026-07-26T15:18:51.345Z Has data issue: false hasContentIssue false

Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy

Published online by Cambridge University Press:  29 June 2007

Walter Habermann*
Affiliation:
Department of ENT, University of Graz, Medical School, Austria.
Andreas Eherer
Affiliation:
Department of Internal MedicineUniversity of Graz, Medical School, Austria.
Franz Lindbichler
Affiliation:
Department of Radiology, University of Graz, Medical School, Austria.
Johann Raith
Affiliation:
Department of Radiology, University of Graz, Medical School, Austria.
Gerhard Friedrich
Affiliation:
Department of ENT, University of Graz, Medical School, Austria.
*
Address for correspondence: W. Habermann, Department of ENT, University of Graz, Medical School, Auenbruggerplatz 20, A-8010 Graz, Austria e-mail: w_habermann@yahoo.com.

Abstract

The aim of this study was to investigate whether patients with chronic posterior laryngitis and symptoms of gastro-pharyngeal reflux benefit from a six-week therapy with pantoprozole. Twenty-nine out-patients with voice disorders (case history of at least two months) and simultaneous symptoms of gastropharyngeal reflux were recruited for this study. At the entry to the study a symptom questionnaire and a videolaryngo/stroboscopy were completed. The symptom questionnaire and the video-laryngo/stroboscopy were repeated after the six weeks of therapy with pantoprazole 40 mg once a day and again six weeks and three months after this follow-up, during which time the patient was without therapy.

Hoarseness, globus pharyngeus, sore throat, heartburn, and coughing were the symptoms which showed a significant (p<0.05) recovery at the follow-ups (mean of hoarseness index: 7.28 to 0.92; mean of globus pharyngeus index: 3.14 to 0.58; mean of heartburn index: 2.86 to 0.5; mean of cough index: 1.72 to 0.25; mean of throat soreness index: 1.72 to 0.15). Laryngoscopy scores of the posterior laryngeal region, the glottic and the supraglottic region showed statistically significant improvement (p<0.05) after the treatment with pantoprazole. The therapeutic effect exceeded the drug administration until the last follow-up (after three months). The medication was tolerated without side-effects in all patients.

A primary (ex juvantibus) therapy with proton pump inhibitors seems to be a therapeutic option for patients with long-lasting chronic inflammation of the larynx not responding to common therapy. In this case a six-week course of treatment has been shown to be sufficient.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable